about
Commercial bovine proteoglycan is highly arthritogenic and can be used as an alternative antigen source for PGIA model.Differential arthritogenicity of Staphylococcus aureus strains isolated from biological samples.Experimental autoimmune encephalomyelitis development is aggravated by Candida albicans infectionTreatment with Vitamin D/MOG Association Suppresses Experimental Autoimmune Encephalomyelitis.Systemic Administration of Proteoglycan Protects BALB/c Retired Breeder Mice from Experimental Arthritis.Persistent inflammation in the CNS during chronic EAE despite local absence of IL-17 productionBCG and BCG/DNAhsp65 vaccinations promote protective effects without deleterious consequences for experimental autoimmune encephalomyelitis.Previous infection with Staphylococcus aureus strains attenuated experimental encephalomyelitis.pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity.Association of myelin peptide with vitamin D prevents autoimmune encephalomyelitis development.Cloxacillin control of experimental arthritis induced by SEC(+) Staphylococcus aureus is associated with downmodulation of local and systemic cytokines.Previous contact with Strongyloides venezuelensis contributed to prevent insulitis in MLD-STZ diabetes.Decreased production of TNF-alpha by lymph node cells indicates experimental autoimmune encephalomyelitis remission in Lewis rats.Bacille Calmette-Guérin/DNAhsp65 prime-boost is protective against diabetes in non-obese diabetic mice but not in the streptozotocin model of type 1 diabetes.Migratory route of Strongyloides venezuelensis in Lewis rats: comparison of histological analyses and PCR.Recovery from Strongyloides venezuelensis infection in Lewis rats is associated with a strong Th2 responseExposure to Mycobacterium avium decreases the protective effect of the DNA vaccine pVAXhsp65 against Mycobacterium tuberculosis-induced inflammation of the pulmonary parenchymaExperimental autoimmune encephalomyelitis evolution was not modified by multiple infections with Strongyloides venezuelensisNeonatal BCG immunization followed by DNAhsp65 boosters: highly immunogenic but not protective against tuberculosis - a paradoxical effect of the vector?Downmodulation of peripheral MOG-specific immunity by pVAXhsp65 treatment during EAE does not reach the CNSAldosterone is not involved in the ventricular remodeling process induced by tobacco smoke exposure
P50
Q33757939-D9C946C0-3A11-4889-B6F1-435918212AD6Q34976399-B2A519B2-29A2-434E-ADE9-42F6D7BE141FQ35563492-6823C3A9-4908-4562-8C3C-06D9DB1041CCQ35597747-FAB3B774-FC6A-4913-BF76-898541A6FA33Q36953054-496EB96E-EB07-4BE8-A774-479B28D48FABQ37010063-93CA882A-BEB6-41EF-870F-FA6766C0479DQ37316205-4B0F174A-E661-41E0-866E-69EC37A9FDB6Q37474212-BBD8B12E-1E3A-466A-B2F2-3AC564C429D3Q37683473-9553DCEF-579D-4225-8AC1-F65E78D82E4EQ40112349-CE5606AC-CDEB-4CBA-A910-9ABC016813D8Q40860604-54977A10-CF09-43ED-A783-D7F5E64345D3Q44061763-A82CBD03-4FB8-4497-B82C-4ADD1AA060A3Q48181269-5306FA0E-9F6F-459C-9A08-D906D16F43D3Q50974904-7081912E-D5DA-44EC-A42C-2AC7E71E02D0Q54413658-4ADA31D7-E0AE-4AFD-824E-07C9BA9FE948Q82367715-C572C3F5-8A11-4F41-BCE6-3C4DD31DA551Q83150493-10DC066E-A36F-4C28-9CC3-8E7CB81ADD07Q83814777-FD5BC83A-2A16-4085-9016-F97E75FF5B34Q84043624-0FEC6022-154C-4AC9-AF23-35B7D5A971E9Q87121531-0ABA74C2-7601-4924-A616-12F562F6B8F7Q87422811-80EDF625-18BB-48F2-AE64-413BF4277B73
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9030-0768
@en
name
Sofia Fernanda Gonçalves Zorzella-Pezavento
@ast
Sofia Fernanda Gonçalves Zorzella-Pezavento
@en
Sofia Fernanda Gonçalves Zorzella-Pezavento
@es
Sofia Fernanda Gonçalves Zorzella-Pezavento
@nl
type
label
Sofia Fernanda Gonçalves Zorzella-Pezavento
@ast
Sofia Fernanda Gonçalves Zorzella-Pezavento
@en
Sofia Fernanda Gonçalves Zorzella-Pezavento
@es
Sofia Fernanda Gonçalves Zorzella-Pezavento
@nl
prefLabel
Sofia Fernanda Gonçalves Zorzella-Pezavento
@ast
Sofia Fernanda Gonçalves Zorzella-Pezavento
@en
Sofia Fernanda Gonçalves Zorzella-Pezavento
@es
Sofia Fernanda Gonçalves Zorzella-Pezavento
@nl
P106
P21
P31
P496
0000-0001-9030-0768